BR9506097A - Peptideo complexo do mesmo reagente marcado com radionucleto de metal composição para radiodiagnóstico e radioterapia uso de um peptideo e processos para diagnóstico e para preparar um peptideo um complexo um reagente e uma composição - Google Patents

Peptideo complexo do mesmo reagente marcado com radionucleto de metal composição para radiodiagnóstico e radioterapia uso de um peptideo e processos para diagnóstico e para preparar um peptideo um complexo um reagente e uma composição

Info

Publication number
BR9506097A
BR9506097A BR9506097A BR9506097A BR9506097A BR 9506097 A BR9506097 A BR 9506097A BR 9506097 A BR9506097 A BR 9506097A BR 9506097 A BR9506097 A BR 9506097A BR 9506097 A BR9506097 A BR 9506097A
Authority
BR
Brazil
Prior art keywords
peptide
complex
composition
reagent
radiodiagnosis
Prior art date
Application number
BR9506097A
Other languages
English (en)
Inventor
Yoshitoshi Itaya
Ikuya Seki
Koichi Hanaoka
Yoshifumi Shirakami
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of BR9506097A publication Critical patent/BR9506097A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR9506097A 1994-12-27 1995-12-27 Peptideo complexo do mesmo reagente marcado com radionucleto de metal composição para radiodiagnóstico e radioterapia uso de um peptideo e processos para diagnóstico e para preparar um peptideo um complexo um reagente e uma composição BR9506097A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33802494 1994-12-27

Publications (1)

Publication Number Publication Date
BR9506097A true BR9506097A (pt) 1997-12-23

Family

ID=18314223

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506097A BR9506097A (pt) 1994-12-27 1995-12-27 Peptideo complexo do mesmo reagente marcado com radionucleto de metal composição para radiodiagnóstico e radioterapia uso de um peptideo e processos para diagnóstico e para preparar um peptideo um complexo um reagente e uma composição

Country Status (14)

Country Link
US (2) US5770178A (pt)
EP (1) EP0719790B1 (pt)
KR (1) KR100385340B1 (pt)
AR (1) AR001781A1 (pt)
AT (1) ATE244726T1 (pt)
AU (1) AU703230B2 (pt)
BR (1) BR9506097A (pt)
CA (1) CA2165228A1 (pt)
DE (1) DE69531230T2 (pt)
DK (1) DK0719790T3 (pt)
ES (1) ES2199974T3 (pt)
NZ (1) NZ280694A (pt)
TW (1) TW514641B (pt)
ZA (1) ZA9510850B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083481A (en) * 1992-05-21 2000-07-04 Diatide, Inc. Thrombus imaging agents
CA2165228A1 (en) * 1994-12-27 1996-06-28 Yoshitoshi Itaya Metal chelate forming peptides and use thereof
WO2002064091A2 (en) * 2001-02-13 2002-08-22 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
JP2002536295A (ja) * 1998-12-14 2002-10-29 パラチン テクノロジーズ, インク. 金属ペプチド組合せライブラリ及びその利用法
US7049398B1 (en) * 1999-08-12 2006-05-23 Palatin Technologies, Inc. Melanocortin metallopeptide constructs, combinatorial libraries and applications
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
JP2003524018A (ja) 2000-02-24 2003-08-12 アイトゲネーシシェ テクニシェ ホッホシューレ チューリッヒ フィブロネクチンのed‐bドメインに特異的な抗体、前記抗体を含む複合体、および血管形成を検出および治療するためのその使用
US7385025B2 (en) * 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
EP1700608A1 (en) * 2005-03-10 2006-09-13 Schering AG Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
WO2006094725A1 (en) * 2005-03-10 2006-09-14 Bayer Schering Pharma Aktiengesellschaft Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
EP2873675A1 (en) * 2013-11-15 2015-05-20 The Medical College of Wisconsin, Inc. Peptide-based peroxidase inhibitors and methods of using same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594593A (en) * 1988-12-17 1997-01-14 Milner; Peter J. Rear view system for a vehicle
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
DK0570493T3 (da) * 1991-02-08 2000-06-26 Diatide Inc Technetium-99m-mærkede polypeptider til billeddannelse.
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
GB9108652D0 (en) * 1991-04-23 1991-06-12 Antisoma Ltd Immunoreactive compounds
JPH04346998A (ja) * 1991-05-24 1992-12-02 Ichikawa Gosei Kagaku Kk 鎖状ペプチドおよびその製造方法
JPH04346999A (ja) * 1991-05-24 1992-12-02 Ichikawa Gosei Kagaku Kk 鎖状ペプチドおよびその製造方法
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5464934A (en) * 1993-05-14 1995-11-07 Mallinckrodt Medical, Inc. Metal chelates as spacer compounds in biologically active peptides
EP0649857B1 (en) * 1993-10-22 1999-01-20 NIHON MEDI-PHYSICS Co., Ltd. Peptide having inflammation affinity and radioactive diagnostic containing the same
US5827498A (en) * 1994-06-07 1998-10-27 Nihon Medi-Physics Co., Ltd. Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide
CA2165228A1 (en) * 1994-12-27 1996-06-28 Yoshitoshi Itaya Metal chelate forming peptides and use thereof

Also Published As

Publication number Publication date
EP0719790B1 (en) 2003-07-09
KR960022558A (ko) 1996-07-18
CA2165228A1 (en) 1996-06-28
US5770178A (en) 1998-06-23
ZA9510850B (en) 1996-06-25
EP0719790A2 (en) 1996-07-03
AR001781A1 (es) 1997-12-10
EP0719790A3 (en) 1997-09-10
ES2199974T3 (es) 2004-03-01
ATE244726T1 (de) 2003-07-15
DK0719790T3 (da) 2003-10-13
KR100385340B1 (ko) 2003-11-14
US5785948A (en) 1998-07-28
NZ280694A (en) 1996-10-28
AU703230B2 (en) 1999-03-18
AU4049595A (en) 1996-07-04
TW514641B (en) 2002-12-21
DE69531230D1 (de) 2003-08-14
DE69531230T2 (de) 2004-06-03

Similar Documents

Publication Publication Date Title
BR9506097A (pt) Peptideo complexo do mesmo reagente marcado com radionucleto de metal composição para radiodiagnóstico e radioterapia uso de um peptideo e processos para diagnóstico e para preparar um peptideo um complexo um reagente e uma composição
BR9607933A (pt) Reagente para preparar um radiofarmacêutico agente de formação de imagem cintigráfica e radioterapêutico complexo composição kit para preparar uma preparação radiofarmacêutica processo para rotular um reagente para formar uma imagem de um sítio e para fazer um reagente composição de matéria e uso do reagente
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
BR1100906A (pt) Composição que é um agente de formação de imagens cintilográficas para mapeamento de sìtios de inflamação em um mamìfero, produto de manufatura compreendendo um kit de elaboração de uma preparação radiofarmacêutica, processo de preparação do reagente, e, composição de matéria
CA2124458A1 (en) Technetium-99m Labeled Peptides for Imaging
IL78993A0 (en) Antibodies and kit for use in radiotherapy and radioimmunoassay utilizing the same
ATE198986T1 (de) Topische zusammensetzung enthaltend ein antagonist der substanz p
IL86577A (en) Antibodies having specific affinity for autocrine motility factor, a kit containing the same, and use thereof to detect the presence of cancer in humans
BR8906422A (pt) Tinta,aplicacao de compostos e composicao
PT938471E (pt) A preparacao e uso de acidos ortosulfonamidoarilhidroxamicos como inibidores de metaloproteinases de matriz e "tace"
IT8519353A0 (it) Composizione farmaceutica e forme farmaceutiche che la contengono
IT1187732B (it) Copolimero contenente fluoro polimerizzabile e composizione liquida di rivestimento che lo utilizza
ID1037B (id) Eter isonitril dan senyawa-senyawa kompleks radioaktifnya
BR8301376A (pt) Valvula para uso em uma coluna de teste de poco
BR9707501A (pt) Composto composição farmacêutica e uso do composto
IT1182712B (it) Composizione colorante e suo uso per la colorazione di materiali termoplastici
DE3274621D1 (en) Radiopharmaceutical composition based on technetium-99m and reagent for making it
BR9707808A (pt) Composto composição farmacêutica e uso do composto
KR950702308A (ko) 분만예정시기를 결정하는 진단방법과 이목적에 사용되는 키트(diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor)
BR8506475A (pt) Composicao de poliester para revestimento
BR9507451A (pt) Composição farmacêutica uso de uma quantidade de (i) um antígeno padronizado em conjunto com uma quantidade de (ii) um polipeptídeo e produto contendo uma quantidade de (i) um antígeno padronizado em conjunto com uma quantidade de (ii) um polipeptídeo
BR9910468A (pt) Composto, complexo radiometálico, preparação para administração em ser humano, kit, usos de um composto e de um complexo radiometálico do composto, e, fragmento de peptìdeo
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
DE3271333D1 (en) Use of esterified oxalkylates as compounding agents for dyes and the corresponding dye preparations
IT1277472B1 (it) Composizione coprente con un film e preparazioni solide che utilizzano la stessa

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FF Decision: intention to grant
FG9A Patent or certificate of addition granted
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A(S) 12A, 13A E 14A ANUIDADES.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2046 DE 23/03/2010, E COMPROVAR O RECOLHIMENTO DA(S) 12A., 13A., 14A., 15A., 16A., E 17A. ANUIDADE(S).

B15K Others concerning applications: alteration of classification

Ipc: C07K 7/08 (2006.01), A61K 51/08 (2006.0